ADDICTION IN PREGNANCY

Similar documents
MAT IN PREGNANCY KAYLA LIFE STAGE 1: ADOLESCENCE LIFE STAGE 2: EARLY ADULTHOOD. family History of addiction. addiction to oral opioids

Medication for the Treatment of Addiction (MAT)

Advancing the Care of Pregnant and Parenting Women with Opioid Use Disorder and their Infants: A Foundation for Clinical Guidance

THE OPIOID CRISIS 9/19/2018 DEFINING THE CRISIS DEFINING THE CRISIS NUMBER OF OPIOID-RELATED OVERDOSE DEATHS IN ALABAMA

Opioids in Pregnancy. Beyond to Baby GENERAL INFO

Neonatal Abstinence: The epidemic Its Impact on All of Us

Opioid Use Disorders and Pregnancy. Marcela Smid, MD Maternal-Fetal Medicine

9/19/13. Postpartum Counseling for Women in MAT. Katie Clark MSPH, CSAC. A little about Katie. Definitions. MAT: Medication-Assisted Treatment

Opioid Use Disorder in Pregnancy. Neonatal Abstinence Syndrome

Neonatal Abstinence Syndrome Questions & Answers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012)

Johann Hari. Truths 2/29/2016. From the street to the NICU. Treatment works

Methadone and Pregnancy

Objectives. Care of the Neonate with Prenatal Opioid Exposure. What is Neonatal Abstinence Syndrome (NAS)? Increasing Incidence of NAS 8/27/2016

PROJECT DOVE. Improving Maternal and Neonatal Health Through Safer Opioid Prescribing MODULE 3

Screening Pregnant and Postpartum Women for Substance Use Disorder. MPQC Fall Summit November 14, 2018

Opioid Use Disorder. in Pregnancy: Care and Context of Mother and Newborn

Running head: NEONATAL ABSTINENCE SYNDROME 1

2/24/2017. Pregnant Women Who Use Drugs: Stigma, Science and Society

Objectives. Nothing to Disclose No Conflicts of Interest

Learning Objectives. Serving Pregnant Women Affected by Substance Use Disorders in Healing to Wellness Court: Sharing Lessons

Maternal Substance Abuse: Challenges & Opportunities for Perinatal Nurses Catherine H. Ivory, PhD, RNC-OB October, 2015

Developing a Clinical Pathway to Improve School-Based Health Care for Adolescent Substance Abuse. Winona Stoltzfus, MD

Pregnancy, Opioid Addiction, and Care Issues in Virginia

The Long-Term Outcomes of Infants with Neonatal Abstinence Syndrome

HELPING OUR MOST VULNERABLE POPULATIONS IMPACTED BY THE OPIOID CRISIS: PREGNANT WOMEN, THEIR INFANTS, AND THOSE RECEIVING CHILD WELFARE SERVICES

NOWS The Time Caring for the Infant with Neonatal Opiate Withdrawal Syndrome

Care of the Neonate with Prenatal Opioid Exposure. Objectives. What is Neonatal Abstinence Syndrome (NAS)/ Neonatal Opiate Withdrawal Syndrome?

Neonatal Abstinence Syndrome Epidemiology, diagnosis, management and prevention

Treating Women for Opioid Use Disorder during Pregnancy: Methadone and Buprenorphine as a Part of a Complete Care Approach

Opioid use in pregnancy and Neonatal Abstinence Syndrome

NAS / NOWS: Description. Disclosures: I will discuss off-label uses of medications I have no financial disclosures. Objectives

Neonatal Abstinence Syndrome:

Understanding Prenatal Drug Exposure

Neonatal Abstinence Syndrome

Talking with your doctor

Women in the Opioid Crisis: Pain, Pregnancy and Life Course

Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC

Consequences and Treatment of Opioid Abuse During Pregnancy. Katie Ellis, PharmD March 12, 2018

ORIGINAL RESEARCH. (J Addict Med 2017;11: )

Effective Management of Substance Use Disorder Patients in an Emergency Department Setting

Prenatal Substance Abuse: Improving Outcomes

Lori A. Shook, MD Division of Neonatology Kentucky Children s Hospital University of Kentucky Medical Center

Screening, Brief Intervention and Referral to Treatment SBIRT

2/28/2017. Substance Use Disorders + Pregnancy. Substance Use Disorders + Pregnancy. + Prevalence of the Problem

Central Appalachia: A Regional Response to an Opioid Epidemic in Pregnancy

Effects of Prenatal Illicit Drug. Use on Infant and Child

Parenting Your Teen in 2016

Medication-Assisted Treatment & Pregnancy. Dave Kneessy, MS, MAC, CAP, LMHC Regional Director Central Florida Treatment Centers

Neonatal abstinence syndrome

Implementation of a Community-Wide Screening and Brief Intervention Project

What To Expect. Maternal Cannabis Use during Pregnancy and the Impacts on Offspring

Outcomes of Infants with Neonatal Abstinence Syndrome

Neonatal Abstinence Syndrome:

Opioid Use in Pregnant Women and Prenatal Care. Murray F Dweck MD, FACOG Medical Director/OBGYN Florida Department of Health -Brevard

Bench Guide for Opioid-Involved Dependency Cases *

Opiate Use in Reproductive Age Females

Neonatal Abstinence Syndrome

The Opioid-Exposed Woman

Managing drug misuse in pregnancy and beyond

Brief History of Methadone Maintenance Treatment

State of the Science on Pregnant and Parenting Women with Substance Use Disorder

Connecticut Adolescent Screening Brief Intervention and Referral to Treatment

TITLE V MATERNAL & CHILD HEALTH 5-YEAR STATE ACTION PLAN

IN-PATIENT PEDIATRIC REHABILITATION

10/26/15. Perspec'ves on maternal opioid use and abuse. Dr. Rita J. Nutt. Our Expectation. Harsh Realities

Name: Date of Birth: Age: Grade: ID Number: Bob M Jones 4/21/ Gender: Sexual Orientation: Sex at Birth: Preferred Pronoun:

Beyond Birth: A Comprehensive Recovery Center serving parenting women

8/27/2018. Katie Brooks, DO, FAAP CHI Health St. Elizabeth. I have nothing to disclose

Disclosures. Objectives 2/5/2018. Women and opioid use disorder: Optimizing care during pregnancy and beyond

EAT, SLEEP, CONSOLE The Yale Method of assessment and treatment of neonates during withdrawal from opiates

Counseling Guidelines: Breastfeeding and Maternal Alcohol, Tobacco and Other Drug Use

KRISANNA DEPPEN, MD FAMILY MEDICINE, ADDICTION MEDICINE GRANT MEDICAL CENTER-OHIOHEALTH COLUMBUS, OH

Treatment of Opioid Use Disorder in Women During Pregnancy and Postpartum

Neonatal Abstinence: It s No Child s Play!

STARTING SUBOXONE IN PRIMARY CARE

Wales Neonatal Network Guideline

Supersedes Date None and Management Guidelines. Originating Dept. NICU Document Owner Dir., NICU Document applies to: NCH Required Not Required

Marijuana During Pregnancy: An Overview

Neonatal Drug Withdrawal

Product Labeling to Communicate Benefits and Risks of Treatment for Opioid Use Disorder in Pregnant Women. Hendrée E. Jones, PhD

SUBOXONE (buprenorphine and naloxone) sublingual film (CIII) IMPORTANT SAFETY INFORMATION

Public Policy Statement on Substance Use, Misuse, and Use Disorders During and Following Pregnancy, with an Emphasis on Opioids

Opioid Overdose Epidemic A Crises and Opportunity

Science = Solutions For Substance Use Disorders and Infant Outcomes. Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse

Emerging Populations: Challenges for the Early Childhood System. Presented by Maureen Greer

Prescription Abuse: Cause, Consequence and Control

Child Welfare and MOMS: Building Partnerships to Improve Care

A New approach to NAS: home in 6 days

Medication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment

Care of the HIV-Exposed Infant

Neonatal Abstinence Syndrome In Kentucky. Annual Report. From the Public Health Neonatal Abstinence Syndrome Reporting Registry

Tobacco Cessation for Women of Reproductive Age. Erin McClain, MA, MPH

The Craffty Pupil Adolescent Substance Abuse Screening and Management

Funding for TIPS provided by: The State of Tennessee Portions of this presentation 2002 The American College of Obstetricians and Gynecologists

Outpatient Treatment for Adolescent Substance Use

Objectives. Common Drugs leading to NAS. Differential Diagnosis. Clinical Features of NAS. Assessing Neonatal Abstinence in the Newborn Nursery

EI Leadership April 24, 2018

Texas Strategies to Address the Opioid Crisis and Neonatal Abstinence Syndrome

The Opiate Crisis 4/6/18. April 9, Words are important. If you want to care for something, you call it a flower.

LifeBridge Physician Network Care Path Depression, Substance Abuse June 26, 2015

Transcription:

ADDICTION IN PREGNANCY R. Corey Waller MD, MS, DFASAM Sr. Medical Director, Education and Policy The National Center for Complex Health and Social Needs

DISCLOSURES No relevant disclosures

OBJECTIVES The learner will: Understand the demographics of pregnancy and addiction Know what screening tools to use Know the medications that assist with opioid use disorder Understand the risk of Neonatal Abstinence Syndrome (NAS) Understand the risks and benefits of breast feeding

DEMOGRAPHICS 15.8 million women (or 12.9 percent) ages 18 or older have used illicit* drugs in the past year. (SAMHSA, 2014)

SCREENING Less than 10 % of OB offices routinely screen for addiction (ACOG) Screening methodologies The T-ACE (Tolerance, Annoyance, Cut Down, Eye Opener) and TWEAK (Tolerance, Worried, Eye-openers, Amnesia, K[C] Cut Down) 4 P s Parents: Did any of your parents have a problem with alcohol or other drug use? Partner: Does your partner have a problem with alcohol or drug use? Past: In the past, have you had difficulties in your life because of alcohol or other drugs, including prescription medications? Present: In the past month have you drunk any alcohol or used other drugs? CRAFFT Substance Abuse Screen for Adolescents and Young Adults C Have you ever ridden in a CAR driven by someone (including yourself) who was high or had been using alcohol or drugs? R Do you ever use alcohol or drugs to RELAX, feel better about yourself, or fit in? A Do you ever use alcohol or drugs while you are by yourself or ALONE? F Do you ever FORGET things you did while using alcohol or drugs? F Do your FAMILY or friends ever tell you that you should cut down on your drinking or drug use? T Have you ever gotten in TROUBLE while you were using alcohol or drugs?

MAT FOR OPIOID USE DISORDER Abstinence Based Treatment Only 16% effective in preventing relapse during pregnancy and less for 1 year retention in treatment (Lund et al., 2012) Methadone 65-80% effective for retention in treatment at 1 year Still considered the gold standard May have a higher drug requirement as pregnancy progresses Buprenorphine 50-65% effective for retention in treatment at 1 year Becoming more prevalent given the MOTHER study Shorter length of stay and less NAS

NEONATAL ABSTINENCE SYNDROME (NAS) Characterized by Hyperactivity, irritability Hypertonia Difficulty/excessive sucking High-pitched cries Initial treatment is supportive Swaddling, frequent feeding, IV fluids Assess regularly for symptoms and failure to thrive Pharmacotherapy Usually opioids, occasionally sedative-hypnotic (phenobarbital) Tincture of opium (old), morphine and methadone Why not Clonidine? (e.g., Coyle et al., 2002; Agthe et al., 2009)

BREASTFEEDING Low doses of buprenorphine and methadone are found in breast milk (e.g., Ilett et al., 201; Jansson et al., 2008b). A study of neonates prenatally exposed to methadone or buprenorphine for a minimum of 30 days found that breastfed neonates had significantly shorter lengths of hospital stay and decreased need for pharmacotherapy for NAS (Wachman et al., 2013) Breastfeeding = increased oxytocin increased reward increased bonding better sleeping better feeding better all around Contraindications HIV positive Active illicit drug use Marijuana use? (probably OK if mother used during pregnancy, given the positives of breastfeeding)

REFERENCES Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National Guidance. Stacey L. Klaman, MPH, Krystyna Isaacs, PhD, Anne Leopold, MSc, Joseph Perpich, MD, JD, Susan Hayashi, PhD, Jeff Vender, MLIS, Melinda Campopiano, MD, and Hendre e E. Jones, PhD. J Addict Med Volume 00, Number 00, Month/Month 2017. Methadone and Buprenorphine for the Management of Opioid Dependence in Pregnancy. Hendre e E. Jones, 1,2 Loretta P. Finnegan, 3,4 and Karol Kaltenbach; Drugs 2012; 72 (6): 747-757. A Practical Guide to Intervention in Health and Social Services with Pregnant and Postpartum Addicts and Alcoholics: Theoretical Framework, Brief Screening Tool, Key Interview Questions, and Strategies for Referral to Recovery Resources. Ewing H. Martinez (CA): The Born Free Project, Contra Costa Department of Health Services; 1990.